Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and β-glucuronidase from human neutrophils
- 1 April 1983
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 89 (1-2) , 19-26
- https://doi.org/10.1016/0014-2999(83)90603-9
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- BRONCHOCONSTRICTION PRODUCED IN MAN BY LEUKOTRIENES C AND DThe Lancet, 1981
- Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboonsInflammation Research, 1981
- Nifedipine in the treatment of prinzmetal's (variant) anginaThe American Journal of Cardiology, 1979
- The role of platelet-activating factor in platelet aggregationNature, 1979
- Treatment of hypertension with nifedipine, a calcium antagonistic agent.Circulation, 1979
- Structural analysis of purified platelet-activating factor by lipasesNature, 1977
- Calcium Antagonists and Islet FunctionHormone Research, 1977
- Calcium-induced lysozyme secretion from human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1974
- Calcium Ionophores and Movement of Calcium Ions following the Physiological Stimulus to a Secretory ProcessNature, 1973
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972